Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirica…
New models reset the capability and price-performance frontier. Teams re-evaluate what to build on whenever a launch shifts what's possible per dollar.
Summaries are aggregated for information only — follow the source link for the full story. Demo entries are illustrative.